m.ndiaye

TL2 · Gdańsk

Contributes reviews on supplier material. Based in Gdańsk.

Joined 12 April 2025 · last posted 2d

85 posts, newest first. Showing up to 150.

eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #39 · Clinical › Bloodwork · 26 Jul 2026 · 0 likes What I would tell a new member reading about egfr fluctuation for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #46 · Practice › Dosing & titration · 25 Jul 2026 · 4 likes Post #42 put the caveat in the right place and I want to underline it. Agreed on four-week escalation interval, with one qualification that I think matters. The…
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #62 · Practice › Interactions · 19 Jul 2026 · 12 likes Everything in post #58 holds. The case it does not cover is the one I have. Oral medications versus time: if you take an oral medication 30 minutes before semaglutide…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #122 · Evidence › Journal club · 16 Jul 2026 · 29 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later. Worth…
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #29 · Clinical › Comorbidities · 11 Jul 2026 · 0 likes Building on post #28 rather than restating it. I keep a log for Osteoarthritis and mechanical versus metabolic specifically because my memory of it turned out to be…
How shortages have affected compounding permissions Replied, post #26 · Access › Shortages · 9 Jul 2026 · 3 likes On shortages, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
Research-use-only status: what it means legally and practically Replied, post #71 · Compounds › Other compounds · 7 Jul 2026 · 5 likes The arithmetic in post #68 is right; the assumption feeding it is the part to check. A compound with no established assay is a compound where a certificate can say…
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #22 · Compounds › Retatrutide · 3 Jul 2026 · 9 likes What would change my mind on glucagon receptor agonist is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would…
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #18 · Evidence › Journal club · 3 Jul 2026 · 2 likes The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to.
Journal club: what we got wrong in an earlier session Replied, post #46 · Evidence › Journal club · 2 Jul 2026 · 0 likes Where I part company with post #44, and it is a narrow parting. A conflict-of-interest statement is worth reading aloud and is worth very little as a predictor. Design…
Comparing documentation quality across the directory, tabulated Replied, post #8 · Sourcing › Vendor reports · 1 Jul 2026 · 4 likes What I want from this comparing documentation quality thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can…
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #84 · Data & Tools › Datasets · 22 Jun 2026 · 31 likes Where a value is derived rather than measured, mark it. Derived columns get treated as observations the moment the file leaves your hands.
Tracking a shortage from primary sources rather than rumour Replied, post #61 · Access › Shortages · 20 Jun 2026 · 4 likes The confident answers on tracking a shortage and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this category.
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #43 · Clinical › Comorbidities · 19 Jun 2026 · 0 likes Post #41 and I disagree about the size of the effect, not about the direction. Age at the extremes of the studied range is an extrapolation in both directions, and the…
AOD-9604 and the fragment hypothesis, revisited — does this still hold? Replied, post #10 · Compounds › Other compounds · 19 Jun 2026 · 5 likes AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent based on theoretical mechanism. The fragment hypothesis — that…
Alcohol: what is documented and what is folklore Replied, post #47 · Practice › Interactions · 8 Jun 2026 · 14 likes The confident answers on alcohol and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this category.
Solubility limits and what a cloudy solution is telling you Replied, post #11 · Pharmacology › Formulation chemistry · 31 May 2026 · 1 like Post #9 is the version of this I will quote in future. One addition. Solubility limits is worth one more sentence than it usually gets, and the sentence is the one…
Why this subcategory is stricter about sourcing than most Replied, post #34 · Compounds › Secretagogues & GH axis · 25 May 2026 · 2 likes The arithmetic in post #33 is right; the assumption feeding it is the part to check. Effects reported at the level of appetite are the most consistently described and…
Revisiting: What pooling buys you and what it destroys Replied, post #29 · Evidence › Meta-analyses · 21 May 2026 · 4 likes Taking post #28 at face value and following it one step further. Double extraction with disagreement resolution is standard and is worth checking for, because single…
Reference intervals: how they are constructed and why one in twenty flags Replied, post #98 · Clinical › Bloodwork · 16 May 2026 · 5 likes That is clearer than the version I had in my head. Thank you.
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #11 · Evidence › Journal club · 30 Apr 2026 · 18 likes Everything in post #7 holds. The case it does not cover is the one I have. The arithmetic on STEP 1 is the easy part and it is where the errors are, which is an…
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #36 · Outcomes › Progress reports · 25 Apr 2026 · 8 likes Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and capability (like climbing stairs without breathlessness) are measurements that…
Converting between mg/mL and units per dose, both directions — the long version Replied, post #51 · Practice › Reconstitution · 21 Apr 2026 · 33 likes Dead volume is the part nobody mentions until it costs them a dose. A fixed-needle insulin syringe holds very little; a detachable-needle luer configuration can hold…
Grapefruit: why this class is not the class that cares Replied, post #61 · Practice › Interactions · 20 Mar 2026 · 13 likes Worth separating two things that post #57 runs together. Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition…
Foaming during reconstitution and whether it matters — the long version Replied, post #62 · Practice › Reconstitution · 13 Mar 2026 · 3 likes That is clearer than the version I had in my head. Thank you.
Search filters: what is missing Replied, post #32 · Meta › Site feedback · 2 Mar 2026 · 11 likes Search and findability: if you searched for something and did not find it, report what you searched for and what you expected to find. That helps improve indexing and…
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #44 · Sourcing › Logistics · 24 Feb 2026 · 16 likes That reframing is the whole thing. The facts I already had.
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #37 · Analytics › Impurities & related substances · 14 Feb 2026 · 9 likes Taking post #34 at face value and following it one step further. Aggregates: multiples of the monomer mass. May not elute at all under a standard reversed-phase method.…
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #31 · Outcomes › Progress reports · 10 Feb 2026 · 8 likes Worth separating two things that post #29 runs together. A single scale used throughout beats a more accurate scale introduced halfway through. Consistency beats…
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #60 · Start Here › How to Ask · 5 Feb 2026 · 31 likes Context that matters: compound, how long in, current dose, relevant history. Context that does not matter: how you feel, your hopes for the outcome, your medical…
Warfarin and altered intake: the monitoring argument — the long version Replied, post #98 · Practice › Interactions · 26 Jan 2026 · 0 likes What I would tell a new member reading about Warfarin and altered intake for the first time: the confident posts are not the reliable ones, and the reliable ones are…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #96 · Compounds › Semaglutide · 18 Jan 2026 · 0 likes Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the stomach empties it feeds less food into the intestines at a time,…
Pregnancy and pregnancy planning: contraindication and washout Replied, post #3 · Clinical › Special populations · 29 Dec 2025 · 25 likes The most useful contribution here is usually a citation to whichever published document comes closest, with a plain statement of how far it is from the question.
Second pass at: Metformin co-administration and additive GI effects Replied, post #24 · Practice › Interactions · 27 Dec 2025 · 31 likes A supplement is a drug for interaction purposes, and the fact that it is sold without a prescription tells you nothing about whether it interacts. The paperwork is…
Tracking a preprint to publication: a worked example Replied, post #67 · Evidence › Preprints · 6 Dec 2025 · 0 likes Post #65 put the caveat in the right place and I want to underline it. Peer review catches some things reliably — missing methods, unsupported conclusions, statistical…
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #68 · Compounds › Oral incretins · 1 Dec 2025 · 4 likes Confirming post #66 from a second method, which matters more than confirming it from a second person. Dose numbers for oral formulations are not comparable to…
Why "add 2 mL" is not an instruction Replied, post #11 · Practice › Reconstitution · 25 Nov 2025 · 5 likes Post #8 answers the question as asked. The question underneath it is different. Preservative effectiveness is tested against a defined microbial challenge under defined…
Why a compound being unapproved is not the same as being illegal to possess Replied, post #34 · Sourcing › Regulatory · 21 Nov 2025 · 20 likes On post #30 — agreed on the reasoning, with one qualification. Research-use-only status is a legal classification, not a safety classification. It means the compound is…
Research-use-only labelling: what it means and what it does not Replied, post #55 · Sourcing › Regulatory · 5 Nov 2025 · 0 likes Coming back to post #53, because the follow-up matters more than the original answer. Research-use-only status is a legal classification, not a safety classification.…
What a purity-only report leaves out Replied, post #73 · Sourcing › Independent verification · 4 Nov 2025 · 2 likes Repeat determination on the same product line months apart is the measurement that speaks to consistency, and consistency is what most buyers actually want.
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #23 · Documentation › Doc review · 21 Oct 2025 · 12 likes Review of promoted topics: when a topic is nominated for promotion to a maintained documentation page, the draft is posted here. Community review happens before…
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #40 · Compounds › Tirzepatide · 20 Oct 2025 · 32 likes The arithmetic in post #39 is right; the assumption feeding it is the part to check. The 2.5 mg starting dose is a tolerance step and not a therapeutic one. Judging…
The headache that turns out to be dehydration Replied, post #5 · Nutrition & Training › Hydration & electrolytes · 23 Sep 2025 · 19 likes Commercial rehydration formulations are designed for a specific purpose and are not equivalent to a sports drink, whatever the marketing suggests. I would rather be…
Guidelines revision: what changed and why — one year on Replied, post #18 · Meta › Announcements · 22 Sep 2025 · 8 likes Taking post #15 at face value and following it one step further. Supportive, with one reservation worth stating in public: the change makes a common case slightly…
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #130 · Evidence › Study critique · 16 Sep 2025 · 24 likes Answering the question post #128 raises rather than the one it answers. Generalisability and validity are separate axes. A trial can be internally impeccable and still…
History of disordered eating and why it changes the conversation Replied, post #12 · Clinical › Special populations · 9 Sep 2025 · 1 like On post #8 — agreed on the reasoning, with one qualification. The failure mode on history of disordered eating is boring rather than dramatic. It is almost always the…
Thyroid function tests during substantial weight change Replied, post #55 · Clinical › Bloodwork · 8 Sep 2025 · 2 likes Worth separating two things that post #54 runs together. I would put moderate confidence on the mainstream reading of thyroid function tests during substantial and no…
Follow-up: Why appetite effects are mostly central Replied, post #24 · Pharmacology › Receptor biology · 24 Aug 2025 · 20 likes I read post #22 twice before replying, because I had assumed the opposite. Species differences in receptor pharmacology are substantial in this family, which is one…
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #87 · Evidence › Journal club · 22 Aug 2025 · 1 like Post #84 answers the question as asked. The question underneath it is different. The baseline characteristics table is the single most useful page for the questions…
Hypertension improvement and when medication needs revisiting Replied, post #3 · Clinical › Comorbidities · 9 Aug 2025 · 1 like Gastrointestinal conditions interact with a mechanism that slows gastric emptying in ways that are plausible and largely unstudied. If anyone has run this properly I…
A request that was declined, and the reasoning — a second dataset Replied, post #33 · Documentation › Wiki requests · 9 Aug 2025 · 2 likes Suggesting content for a page: if you know a maintained page is missing something important, post a suggestion with specific content you think should be added. That is…
A preprint whose numbers changed substantially at publication Replied, post #9 · Evidence › Preprints · 3 Aug 2025 · 29 likes Where I part company with post #7, and it is a narrow parting. How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted…
Are there stupid questions here? A staff answer, at length Replied, post #36 · Start Here › Welcome · 3 Aug 2025 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Canadian access and provincial variation — one year on Replied, post #45 · Regional › North America · 29 Jul 2025 · 6 likes Everything in post #43 holds. The case it does not cover is the one I have. Small methodological point on Canadian access and provincial variation: repeating a…
Journal club: STEP 8 and the fairness of the comparator dose Replied, post #7 · Evidence › Journal club · 26 Jul 2025 · 24 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
Pinch or no pinch, and how needle length changes the answer Started this topic · Practice › Administration · 25 Jul 2025 · 54 likes Pinch or no pinch, and how needle length changes the answer Writing it up because I had to work it out twice and would rather nobody else did. A question about pinch…
A field-by-field walk through a certificate of analysis Replied, post #132 · Analytics › COA interpretation · 18 Jul 2025 · 8 likes Post #128 put the caveat in the right place and I want to underline it. What fields matter on a certificate: lot number matching the vial, test date, the analytical…
Ipamorelin selectivity claims and where they came from Replied, post #52 · Compounds › Secretagogues & GH axis · 30 Jun 2025 · 21 likes I read the earlier replies on ipamorelin selectivity claims twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with…
Half-life, steady state, and accumulation worked through Replied, post #65 · Pharmacology › Pharmacokinetics · 4 Jun 2025 · 7 likes Bookmarking this. I will come back when I have something worth adding.
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #5 · Access › Insurance & coverage · 1 Jun 2025 · 8 likes Practical note on Reading a denial letter: write down what you expect before you look. The number of times I have found what I went looking for is higher than chance…
Second pass at: Trial registration and comparing the protocol with the paper Replied, post #5 · Evidence › Trials · 30 May 2025 · 15 likes Subgroup analyses are hypothesis-generating unless pre-specified and adequately powered, and almost none are the second. The interaction test matters more than the…
Reading a trial's population section before its results — does this still hold? Replied, post #149 · Evidence › Trials · 26 May 2025 · 0 likes Registration before enrolment, with the primary endpoint declared, is what makes outcome switching detectable. Checking the registry against the paper takes five…
Triple agonism: additive, synergistic, or neither? Replied, post #49 · Compounds › Retatrutide · 23 May 2025 · 0 likes On triple agonism, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is the…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #74 · Sourcing › Independent verification · 10 May 2025 · 15 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
Follow-up: What other technical communities get right that we do not Replied, post #83 · Lounge › Off topic · 30 Apr 2025 · 0 likes Not a rules-free zone: the guidelines still apply. No contact details, no invitations to take a conversation off the site, no endorsements of other communities. Just a…
Hepatic steatosis: what the MASH trial evidence supports Replied, post #29 · Clinical › Comorbidities · 29 Apr 2025 · 9 likes I would be cautious about generalising from the hepatic steatosis example above. It is a good example. It is one example.
Second pass at: Reading a combination trial: attributing effect to components Replied, post #4 · Compounds › Cagrilintide & amylin analogues · 7 Apr 2025 · 0 likes The CagriSema phase 2 paper: a fixed combination of the two components in one weekly injection. The trade-off of a fixed combination is that you cannot titrate the…
Scheduled maintenance and what will be unavailable Replied, post #84 · Meta › Announcements · 24 Mar 2025 · 0 likes Post #83 is the version of this I will quote in future. One addition. Worth saying publicly: stepping back cleanly and handing over is a service. Documents with an…
Requesting a page: what makes a good request Replied, post #30 · Documentation › Wiki requests · 21 Mar 2025 · 11 likes Accessibility feedback: if you have trouble accessing or reading a maintained page (screen reader issues, contrast problems, small text) report it. Accessibility…
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #5 · marked as the solution · Evidence › Journal club · 20 Feb 2025 · 17 likes What I want from this SURMOUNT-OSA thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
How compounding permissions changed when supply normalised Replied, post #19 · Sourcing › Regulatory · 14 Feb 2025 · 5 likes I think the compounding permissions question is answerable and has not been answered, which is a more optimistic position than most of this thread.
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #93 · Evidence › Meta-analyses · 11 Feb 2025 · 2 likes Double extraction with disagreement resolution is standard and is worth checking for, because single extraction errors are common and non-random.
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #40 · Compounds › Secretagogues & GH axis · 31 Jan 2025 · 17 likes The pulsatile character of endogenous growth hormone release is why a secretagogue and exogenous growth hormone are not interchangeable, and why a single measured level…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #140 · Clinical › Prescriber conversations · 6 Jan 2025 · 13 likes Post #136 put the caveat in the right place and I want to underline it. Bringing a record of symptoms with dates and severities makes an assessment materially easier…
A promotion I argued against, and why I lost Replied, post #26 · Documentation › Doc review · 10 Dec 2024 · 1 like Check the links. Promotion frequently breaks a cross-reference because the source topic now points at the document rather than the reverse. Caveat: everything above…
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #13 · Practice › Reconstitution · 13 Nov 2024 · 0 likes A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently…
How to ask for a dose change without antagonising anyone — what changed since Replied, post #55 · Clinical › Prescriber conversations · 12 Nov 2024 · 0 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #99 · Analytics › COA interpretation · 29 Oct 2024 · 0 likes Post #97 is right about the mechanism and I think understates the practical bit. Small methodological point on field-by-field walk through a certificate: repeating a…
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #21 · Practice › Interactions · 29 Oct 2024 · 0 likes On Grapefruit the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #45 · Compounds › Retatrutide · 18 Sep 2024 · 15 likes Something worth flagging about hepatic effects of glucagon receptor: the strongest-sounding claims in this thread are the ones with no source attached, which is the…
Blind submission and why it changes minds Replied, post #53 · Sourcing › Independent verification · 5 Sep 2024 · 2 likes Post #52 is right about the mechanism and I think understates the practical bit. Blind submission looks different depending on whether you are reading the primary…
Promotion criteria, and the one that stops most nominations Replied, post #31 · Documentation › Doc review · 4 Aug 2024 · 1 like Post #30 is right about the mechanism and I think understates the practical bit. Agreed on promotion criteria, with one qualification that I think matters. The…
Signs of dehydration worth acting on Replied, post #2 · Safety › Adverse events · 3 Aug 2024 · 10 likes On signs of dehydration worth acting, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the…
Why I ask for the gradient before I discuss the number Replied, post #10 · Analytics › HPLC & UHPLC · 31 Jul 2024 · 6 likes Narrowing post #7, because the general version has more than one answer. Before anything else: what was the gradient, and at what wavelength? Area percent at different…
The mass-error checker and its intended scope Replied, post #36 · Data & Tools › Calculators · 8 Jun 2024 · 6 likes Same experience here, different supplier, so it is at least not unique to one of them.